Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
0.135mg MAP0010
DRUG
2 trials
Sponsors
Allergan
Conditions
Asthma
Phase 3
A Study of 2 Doses of MAP0010 and Placebo in Asthmatic Children
Completed
NCT00569192
Allergan
Asthma
Start: 2007-12-31
End: 2009-01-31
Updated: 2014-01-09
A Study of 2 Doses of MAP0010 in Asthmatic Children
Terminated
NCT00697697
Allergan
Asthma
Start: 2008-04-30
End: 2009-12-31
Updated: 2014-01-09